These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9922920)

  • 1. [Opipramol in comparison to other drugs--new pharmacologic data].
    Müller WE; Siebert B
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S9-12. PubMed ID: 9922920
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific modulation of sigma binding sites by the anxiolytic drug opipramol.
    Holoubek G; Müller WE
    J Neural Transm (Vienna); 2003 Oct; 110(10):1169-79. PubMed ID: 14523629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropharmacology of the anxiolytic drug opipramol, a sigma site ligand.
    Müller WE; Siebert B; Holoubek G; Gentsch C
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S189-97. PubMed ID: 15547785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Postsynaptic attack of tricyclic antidepressive agents in the circulatory system].
    Bobkiewicz T; Chodera A; Szpunar K; Drutel B
    Acta Biol Med Ger; 1975; 34?710():1675-9. PubMed ID: 1233850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Opipramol in behavioral pharmacologic anxiety and depression models].
    Gentsch C
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S17-20. PubMed ID: 9922922
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of tricyclic antidepressant drugs on experimental arterial hypertension.
    Bobkiewicz T; Chodera A; Okulicz-Kozaryn I; Nowakowska E
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):543-7. PubMed ID: 1164154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics and relative bioavailability of opipramol in the new INSIDON--sustained release preparation].
    Nilsson EB; Rimmele SM; Schmidt EK; Antonin KH; Bieck PR
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S13-6. PubMed ID: 9922921
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of various tricyclic antidepressive agents on the estrous cycle of the female rat].
    Lanza M; Chichmanian RM; Goude F
    C R Seances Soc Biol Fil; 1970; 164(6):1300-3. PubMed ID: 4252365
    [No Abstract]   [Full Text] [Related]  

  • 9. [Opipramol (Insidon) in the treatment of somatoform disorders].
    Freyberger HJ; Grabe HJ; Maier W; Janca A; Stoll KD
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S25-30. PubMed ID: 9922924
    [No Abstract]   [Full Text] [Related]  

  • 10. [Opipramol in anxiety and somatoform disorders. Results of a controlled study].
    Volz HP; Möller HJ
    Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S21-4. PubMed ID: 9922923
    [No Abstract]   [Full Text] [Related]  

  • 11. Some central effects of opipramol given repeatedly.
    Skuza G; Rogóz Z; Sowińska H
    Pol J Pharmacol Pharm; 1990; 42(5):425-31. PubMed ID: 2098752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Contribution to the pharmacology of antidepressants of tricyclic structure. (Review)].
    Polezhaeva AI
    Farmakol Toksikol; 1967; 30(2):243-9. PubMed ID: 4177249
    [No Abstract]   [Full Text] [Related]  

  • 13. Tricyclic antidepressant drugs: pharmacologic implications in the treatment of chronic orofacial pain.
    Hersh EV
    Compendium; 1987 Oct; 8(9):688, 690, 692-4. PubMed ID: 3481289
    [No Abstract]   [Full Text] [Related]  

  • 14. On the central antiserotonin activity of benzoctamine and opipramol.
    Przegaliński E; Baran L; Palider W; Bigajska K
    Pol J Pharmacol Pharm; 1978; 30(6):781-90. PubMed ID: 582625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opipramol as nighttime medication.
    Leutgeb U
    Dtsch Arztebl Int; 2009 May; 106(18):321; author reply 321-2. PubMed ID: 19547730
    [No Abstract]   [Full Text] [Related]  

  • 16. [The radioprotective effects of psychotropic drugs].
    Locker A; Ellegast H
    Strahlentherapie; 1966 Feb; 129(2):273-81. PubMed ID: 5984061
    [No Abstract]   [Full Text] [Related]  

  • 17. Poisoning by tricyclic antidepressant drugs: general and pharmacokinetic considerations.
    Bickel MH
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):145-76. PubMed ID: 237840
    [No Abstract]   [Full Text] [Related]  

  • 18. The Dopamine Receptor Antagonism of Opipramol: Relevance to Parkinsonism?
    Rozanski V; Laux G; Schwarz J
    Clin Neuropharmacol; 2019; 42(3):77-79. PubMed ID: 30829882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are receptor studies useful for clinical practice?
    Richelson E
    J Clin Psychiatry; 1983 Sep; 44(9 Pt 2):4-9. PubMed ID: 6313632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of opipramol and metabolic inhibitors on active sodium transport].
    Wiglusz Z; Szadujkis-Szadurski L; Dziubiński Z
    Pol Tyg Lek; 1981 Jul; 36(30):1149-52. PubMed ID: 6975928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.